
With surging healthcare demand worldwide, rising R&D spending, and advanced technologies like AI, data analytics, and IoT transforming drug discovery and development, the pharmaceutical industry is expected to witness significant growth and expansion.
Given the industry’s bright prospects, investors could consider buying fundamentally sound pharma stocks MEI Pharma, Inc. (MEIP), Hypera S.A. (HYPMY), Aurinia Pharmaceuticals Inc. (AUPH), and Bayer Aktiengesellschaft (BAYRY) for substantial gains.